MedTrace Logo

Carbetocin Versus Ergometrin in the Prevention of Postpartum Hemorrhage

NCT04300452 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2020-03-09

No results posted yet for this study

Summary

In the present study will be compared Carbetocin with ergometrin in the prevention of postpartum haemorrhage (PPH) in parturients that are undergoing caesarean section and are not presenting risk factors for PPH. As indicators will be used intraoperative blood loss, as well as the value of hemoglobin and hematocrit 24 hours after the caesarian section.

Conditions

  • Postpartum Hemorrhage

Interventions

DRUG

Carbetocin

Administration of Carbetocin after placental detachment

DRUG

Ergometrine Maleate

Administration of ergometrin after placental detachment

Sponsors & Collaborators

  • National and Kapodistrian University of Athens

    lead OTHER

Principal Investigators

  • Nikoleta Iakovidou · Professor of Pediatrics NKUAthens

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-04-05
Primary Completion
2020-06-10
Completion
2020-09-30

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04300452 on ClinicalTrials.gov